Overview
X-linked ichthyosis syndrome (also known as steroid sulfatase deficiency syndrome, STS deficiency, or X-linked recessive ichthyosis) is a genetic skin disorder caused by deficiency or absence of the enzyme steroid sulfatase (STS), encoded by the STS gene on the X chromosome. In most cases, the condition results from a complete deletion of the STS gene. It predominantly affects males and is one of the more common forms of ichthyosis. The condition is characterized by the accumulation of cholesterol sulfate in the skin, leading to abnormal desquamation and the formation of dark, adherent, polygonal scales, particularly on the trunk, extremities, and neck, while typically sparing the palms, soles, and flexural areas. The skin manifestations usually appear within the first few months of life, often presenting initially as peeling or dry skin in the neonatal period. The scaling tends to worsen with age and is more prominent in cold, dry weather. Beyond the skin, X-linked ichthyosis syndrome can be associated with several extracutaneous features. Corneal opacities (corneal stromal punctate opacities) are found in a significant proportion of affected males and female carriers but typically do not affect vision. Cryptorchidism (undescended testes) occurs in approximately 20% of affected males and may increase the risk of testicular cancer if uncorrected. Some patients may have an increased risk of attention deficit disorders or other neurodevelopmental issues. Maternal carriers may experience prolonged or failure to progress in labor due to placental sulfatase deficiency, which impairs estrogen production necessary for cervical ripening. There is currently no cure for X-linked ichthyosis syndrome. Treatment is primarily symptomatic and focuses on skin care, including regular use of emollients and keratolytic agents such as urea-containing creams, lactic acid preparations, or propylene glycol to reduce scaling and improve skin hydration. Topical retinoids may be used in some cases. Monitoring for cryptorchidism in affected males is important, and surgical correction (orchidopexy) should be performed if needed. Ophthalmologic evaluation may be recommended to assess for corneal opacities. Genetic counseling is advised for affected families.
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for X-linked ichthyosis syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for X-linked ichthyosis syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to X-linked ichthyosis syndrome.
Community
No community posts yet. Be the first to share your experience with X-linked ichthyosis syndrome.
Start the conversation →Latest news about X-linked ichthyosis syndrome
No recent news articles for X-linked ichthyosis syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about X-linked ichthyosis syndrome
What is X-linked ichthyosis syndrome?
X-linked ichthyosis syndrome (also known as steroid sulfatase deficiency syndrome, STS deficiency, or X-linked recessive ichthyosis) is a genetic skin disorder caused by deficiency or absence of the enzyme steroid sulfatase (STS), encoded by the STS gene on the X chromosome. In most cases, the condition results from a complete deletion of the STS gene. It predominantly affects males and is one of the more common forms of ichthyosis. The condition is characterized by the accumulation of cholesterol sulfate in the skin, leading to abnormal desquamation and the formation of dark, adherent, polygo
How is X-linked ichthyosis syndrome inherited?
X-linked ichthyosis syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does X-linked ichthyosis syndrome typically begin?
Typical onset of X-linked ichthyosis syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat X-linked ichthyosis syndrome?
1 specialists and care centers treating X-linked ichthyosis syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.